TAO Synergies, a crypto treasury focused on the Bittensor ecosystem, announced which has entered into a private placement agreement to raise $11 million. The transaction involves the issuance of 11.000 Series E convertible preferred shares, each with a stated value of $1.000, convertible into common shares at $8 per share.
The investor group includes existing investors, strategy consultant James Altucher, and new investor DCG. The transaction is expected to close around October 15, 2025, provided customary closing conditions are met.
According to Altucher,
“TAO Synergies’ latest funding further reinforces its continued strategic investments not only in TAO tokens, but also in potential opportunities to earn revenue and accumulate additional TAO within the Bittensor ecosystem.”
The statement reinforces that part of the funds will be allocated not only to acquiring tokens, but also to exploring revenue sources in the ecosystem.
By June 2025, TAO Synergies had left behind its origins as a biotechnology company called Synaptogenix. In the process, it adopted a new name and changed its ticker to TAOX, adjusting its focus to a Bittensor-centric strategy. The company states that all TAO tokens acquired will be invested to generate rewards on the network.
Bittensor converges artificial intelligence and cryptocurrencies: users contribute AI capabilities and, in return, are rewarded in TAO tokens based on their usefulness to the network. It is an open platform that requires no permissions to participate.
Internal data indicates that TAO Synergies holds approximately 42.111 TAO shares, valued at over $18,2 million, making it the largest publicly traded holder in the Bittensor ecosystem. Other treasuries linked to the ecosystem include xTAO Inc. and Oblong.
Although the announcement came after the markets closed, the news drove a 38,5% jump in TAO Synergies' shares that Monday. The price reached $9,54, and its market capitalization approached $33,27 million, a rise of about 60% in the month leading up to the announcement.